LASIK Surgery — Cost, Top Hospitals & Success Rates | MyMedicPlus

LASIK (Laser-Assisted In Situ Keratomileusis) is the world's most performed elective surgical procedure, with an estimated 700,000–800,000 procedures performed annually in the United States alone and over 35 million cumulative procedures globally. It permanently reshapes the corneal stroma — the central structural layer of the cornea — to correct refractive errors including myopia (near-sightedness), hyperopia (far-sightedness), and astigmatism, reducing or eliminating dependence on spectacles and contact lenses.

LASIK surgery involves two laser systems working in sequence. The first laser creates a thin, hinged corneal flap. The second laser reshapes the corneal stroma beneath. The flap is then repositioned to act as a natural biological bandage. The entire procedure takes approximately 10–15 minutes per eye, and meaningful visual recovery begins within hours.

Modern LASIK is a highly evolved surgical procedure incorporating advanced diagnostic mapping, femtosecond laser precision, and multiple excimer laser ablation profiles. Understanding the surgical mechanics — rather than viewing LASIK simply as a pair-of-glasses alternative — allows patients to make genuinely informed decisions and understand the basis for eligibility criteria, potential complications, and long-term visual expectations.

LASIK corrects refractive errors by changing the curvature of the anterior corneal surface, altering its focusing power:

Myopia (Near-Sightedness)

In myopia the eye is too long relative to its corneal curvature, causing light to focus in front of the retina. LASIK flattens the central cornea to reduce curvature and bring the focal point back to the retinal plane. Standard LASIK platforms are FDA-approved for myopic corrections up to approximately -12.00 dioptres (D), though the safest range is -1.00 D to -8.00 D. Higher corrections remove more stromal tissue, reducing the residual stromal bed and increasing ectasia risk.

Hyperopia (Far-Sightedness)

In hyperopia the eye is too short or the cornea too flat, causing light to focus behind the retina. LASIK steepens the corneal periphery to increase curvature. Hyperopic LASIK is approved for up to approximately +6.00 D, though outcomes are less stable than myopic correction due to peripheral ablation regression over time. Patients over 40 with hyperopia should be counselled about presbyopia (discussed in the LASIK Treatment guide).

Astigmatism

Astigmatism arises from an irregularly shaped cornea with different radii of curvature in different meridians. Excimer laser ablation is delivered in a toric pattern to selectively steepen or flatten the appropriate corneal meridians. LASIK corrects astigmatism up to approximately ±6.00 D cylinder reliably, with good outcomes for up to ±3.00 D in clinical practice.

Mixed Astigmatism

A combination of myopic astigmatism in one meridian and hyperopic astigmatism in the other. Topography-guided LASIK (Contoura Vision) has demonstrated superior outcomes for mixed astigmatism compared to standard wavefront-optimised ablations.

LASIK eligibility is determined through a comprehensive pre-operative assessment. Strict screening prevents most serious complications, particularly corneal ectasia. The following criteria represent current evidence-based standards:

Corneal Thickness

The single most critical eligibility parameter. Minimum pre-operative corneal thickness of approximately 500 micrometres (µm) is required. The excimer laser ablation removes approximately 12–13 µm of stroma per dioptre of myopic correction. FDA and international guidelines require a minimum residual stromal bed (RSB) of 250 µm after flap creation and ablation. Corneas thinner than 480–500 µm, or those where the ablation would leave an RSB under 250 µm, are typically excluded from LASIK and directed toward surface ablation (PRK) or SMILE.

Stable Refraction

Refractive prescription must be stable for at least 12 months prior to surgery (confirmed by comparing two refraction records spaced at least 1 year apart). Progressive myopia — particularly in young patients — increases the risk of post-operative regression and is a relative contraindication.

Age

Minimum age of 21 years (18 in some jurisdictions with stable refraction). Many surgeons prefer age 23–25 for younger patients with high myopia to ensure refractive stability. There is no upper age limit, though presbyopia management must be discussed in patients over 40.

Corneal Topography

Topographic mapping (Placido disc or Scheimpflug imaging) is mandatory to exclude keratoconus and subclinical keratoconus (forme fruste keratoconus) — the primary risk factor for post-LASIK ectasia. Keratoconus-suspect patterns (inferior steepening, asymmetric bowtie patterns, abnormal posterior elevation maps) are absolute contraindications to LASIK. These patients may be candidates for SMILE or surface ablation if the topography is borderline, or for collagen cross-linking if keratoconus is confirmed.

Additional Exclusion Criteria

• Severe pre-operative dry eye syndrome (Schirmer test <5 mm/5 min; TBUT <5 seconds)
• Active autoimmune disease (lupus, rheumatoid arthritis — impairs healing)
• Uncontrolled diabetes mellitus (epithelial healing impairment)
• Pregnancy or breast-feeding (hormonal refractive fluctuation)
• History of herpes simplex keratitis (excimer laser can trigger reactivation)
• Pupil diameter >7 mm in scotopic conditions (risk of night halos exceeds ablation optical zone)

LASIK surgery involves two distinct technical stages — flap creation and stromal ablation — each with multiple platform options:

Stage 1: Flap Creation

Femtosecond Laser (IntraLASIK / Bladeless LASIK)

The femtosecond laser (1,053 nm infrared, ultrashort pulse duration 10-15 femtoseconds) creates the corneal flap through photodisruption — precisely focused pulses create a series of adjacent microcavitation bubbles that cleave the corneal stroma at a programmable depth, typically 100–120 µm. The flap is created plane-parallel, with uniform thickness edge-to-edge. Platforms include the Ziemer LDV, iFS (Abbott), FS200 (WaveLight/Alcon), FEMTO LDV Z8, and IntraLase (now Abbott/J&J). Femtosecond flaps have lower rates of buttonhole, incomplete flap, and free cap compared to microkeratome. Flap dislocation risk is less than 0.1% with femtosecond laser due to superior edge architecture.

Microkeratome (Mechanical)

A motorised oscillating metal blade creates the corneal flap by translation across a suction ring. Platforms include the Hansatome, M2 (Moria), and Zyoptix XP. Flap thickness is less uniform than femtosecond laser. Microkeratome LASIK remains safe and effective but is less common in newer facilities. Risk of flap irregularity is slightly higher, and the blade-created flap has a less precise, curved hinge architecture.

Stage 2: Excimer Laser Ablation

The excimer laser (193 nm argon fluoride) ablates corneal stroma through photoablation — breaking molecular bonds without thermal damage to adjacent tissue. Three ablation profiles are in clinical use:

Wavefront-Guided LASIK

Uses a wavefront aberrometry map (Hartmann-Shack sensor) of the individual eye to create a customised ablation profile that corrects both lower-order aberrations (sphere and cylinder) and higher-order aberrations (coma, trefoil, spherical aberration). FDA-approved wavefront-guided platform: VISX STAR S4 IR (Johnson & Johnson Vision) with iDesign system. Meta-analyses show superior night vision and contrast sensitivity compared to conventional LASIK, and lower induction of higher-order aberrations.

Wavefront-Optimised LASIK

Does not use individual aberrometry but applies a pre-programmed peripheral blend zone that reduces spherical aberration induction during treatment. The primary platform is the WaveLight EX500 (Alcon), the fastest FDA-approved excimer laser (repetition rate 500 Hz, full correction in approximately 5 seconds for -3.00 D myopia). Outcomes are comparable to wavefront-guided in low-to-moderate myopia; the high repetition rate reduces treatment time and eye-tracking error risk.

Topography-Guided LASIK (Contoura Vision)

Uses anterior corneal topographic data (8,000+ points) from the Topolyzer Vario to create an ablation profile that corrects irregular corneal surface higher-order aberrations, including pre-existing higher-order aberrations not detected by wavefront aberrometry. FDA-approved for myopia with or without astigmatism on the Alcon Contoura Vision / WaveLight EX500 platform. Clinical trials (TROPHY) showed that 65% of topography-guided patients achieved vision better than 20/20 uncorrected, compared to 49% with optimised LASIK. Particularly beneficial for patients with irregular corneas.

Intraoperative Eye Tracking

All modern excimer platforms incorporate high-speed iris registration and pupil tracking (250–1,050 Hz) to compensate for involuntary eye movements during ablation, maintaining centration and preventing eccentric ablation that would induce coma and irregular astigmatism.

LASIK delivers reliably excellent visual outcomes in appropriately selected patients, making it the most patient-satisfaction-rated elective surgical procedure in medicine:

• Rapid visual recovery: Approximately 90% of patients achieve 20/20 or better uncorrected distance visual acuity (UDVA) by day 1 post-operatively. Vision continues to stabilise over 1–3 months.
• High efficacy: Over 95% of patients achieve uncorrected vision of 20/40 or better (the legal driving standard in most countries) after a single treatment.
• Permanence: The stromal refractive change is permanent, though natural age-related refractive change (particularly presbyopia after age 40) occurs independently of the LASIK result.
• Bilateral same-day treatment: Both eyes are typically treated in the same session (bilateral simultaneous LASIK), and patients can see well enough to drive within 24–48 hours.
• Freedom from contact lens complications: Eliminating long-term contact lens wear reduces exposure to contact lens-associated microbial keratitis, hypoxia-related neovascularisation, and giant papillary conjunctivitis.
• Quality of life: Multiple validated questionnaires including the NEI-RQL-42 and VFQ-25 demonstrate significant, sustained improvement in visual function-related quality of life following LASIK versus spectacle or contact lens correction.
• Enhancement retreatment: If myopic regression or residual refractive error occurs, enhancement retreatment (re-lifting the flap or surface ablation over it) is possible in most patients with adequate residual stromal tissue, typically needed in 1–5% of cases.

LASIK is safe in appropriately selected patients, but carries a defined spectrum of complications that must be disclosed pre-operatively:

Dry Eye Disease

The most common post-LASIK complication. LASIK severs corneal stromal nerves during flap creation, reducing corneal sensitivity and tear reflex stimulation, and disrupting goblet cell-mediated mucin secretion. 15–20% of patients develop clinically significant dry eye post-LASIK, typically manifesting as foreign body sensation, fluctuating vision, and light sensitivity in the first 3–6 months. In most patients, corneal re-innervation over 6–12 months resolves the dry eye. Severe, persistent dry eye occurs in approximately 2–3% and may require long-term artificial tears, punctal plugs, or cyclosporine 0.05% eye drops. Pre-existing dry eye is a relative contraindication; SMILE (which creates a smaller intrastromal incision) or surface ablation (PRK) have lower dry eye risk.

Corneal Ectasia

The most feared serious complication. Post-LASIK ectasia is a progressive corneal thinning and forward bulging resembling keratoconus that develops months to years after surgery. Incidence in properly screened patients is 0.04–0.6%. Risk factors include undetected forme fruste keratoconus, excessive tissue removal (insufficient RSB), and young age. Management options include rigid gas-permeable contact lenses, corneal cross-linking (CXL) to halt progression, and ultimately corneal transplantation (DALK) in severe cases.

Flap-Related Complications

• Flap dislocation: Less than 0.1% with femtosecond laser flaps. Risk persists lifelong — patients should disclose LASIK history before any eye trauma or contact sport. A dislocated flap is a medical emergency requiring prompt surgical repositioning.
• Diffuse lamellar keratitis (DLK) — 'Sands of the Sahara': Sterile inflammation in the flap interface occurring in the first 5 days post-operatively. Usually responds to intensive topical steroids; severe cases require flap irrigation.
• Epithelial ingrowth: Corneal epithelial cells migrate under the flap edge (1–2% incidence). Usually self-limiting; significant cases require flap lifting and epithelial removal.

Optical Side Effects

Halos, glare, and starbursting around lights at night affect 15–25% of patients in the first 3 months and typically improve as pupil-diameter-to-optical-zone ratio normalises. Persistent symptomatic night vision disturbance occurs in approximately 1–3%. Wavefront-guided and topography-guided ablations reduce induction of higher-order aberrations and have better night vision profiles than conventional LASIK.

Under/Over-Correction and Regression

Residual refractive error affects 5–10% of patients (predominantly myopes with high prescriptions). Myopic regression — gradual return of mild myopia over years — is more common in high myopes. Enhancement retreatment or spectacle wear for residual prescription are the management options.

Post-operative management is critical to outcomes and complication detection. The standard follow-up protocol is:

Immediate Post-Operative Period (Days 1–7)

A protective clear shield is taped over the eye for sleep on the night of surgery to prevent accidental flap rubbing. Topical antibiotic eye drops (moxifloxacin or ofloxacin) are used for 5–7 days to prevent infection. Topical corticosteroid drops (prednisolone acetate 1%) are used for 7–14 days to reduce inflammation and modulate wound healing. Artificial tear drops are used frequently (initially hourly) to manage early dry eye. Patients are reviewed on day 1 for visual acuity, flap assessment, and IOP measurement.

First Month

Follow-up visits at day 7 and day 30. Topical steroids are typically tapered over 2–4 weeks. By day 30 the refractive result is becoming stable for low-to-moderate myopia. DLK and epithelial ingrowth, if they occur, typically manifest in this window.

3 and 6 Months

Formal refraction, UDVA, and corneal topography to assess refractive stability and detect any ectasia signal. Dry eye symptoms are re-evaluated and treatment adjusted. If residual refractive error is present and stable, enhancement candidacy is discussed (enhancement should be deferred until refraction has been stable for 3 months).

12 Months and Annual Review

One-year review is recommended for final UDVA documentation and to identify late-onset ectasia (though most cases manifest within 5 years, cases have been reported up to 12 years post-operatively). Annual follow-up is advisable for patients with high myopic corrections, thin corneas, or any borderline pre-operative topography.

Lifetime Considerations

LASIK patients must inform future ophthalmologists of their surgery history, as the corneal shape changes alter intraocular pressure (IOP) tonometry readings and IOL power calculations for cataract surgery. Dedicated LASIK-adjusted IOL calculation formulas (Barrett True-K, Haigis-L, Kane) are required for accurate cataract surgery planning.

LASIK cost varies substantially based on technology platform, geographic location, surgeon experience, and the extent of pre- and post-operative care included:

Cost-Influencing Factors

• Laser platform: Femtosecond IntraLASIK costs more than microkeratome LASIK due to femtosecond laser equipment cost and disposable interface costs. Topography-guided (Contoura) and wavefront-guided ablations typically carry a premium over standard wavefront-optimised treatment.
• Diagnostic workup: High-resolution corneal tomography (Pentacam, Orbscan), wavefront aberrometry, and aberration-free biometry are often included in comprehensive LASIK packages.
• Enhancement inclusion: Premium centres include a lifetime enhancement guarantee, covering retreatment if regression occurs, which adds to the initial quoted price but reduces long-term cost.
• Surgeon experience: Fellowship-trained cornea/refractive surgeons at established centres typically charge more but have lower complication rates.

Approximate Pricing (Per Eye, Both Eyes Treated)

• India: INR 20,000–80,000 per eye (USD 240–960); femtosecond LASIK at premium centres INR 50,000–80,000
• United States: USD 1,500–3,500 per eye; average USD 2,200 per eye for all-laser (IntraLASIK) with wavefront
• United Kingdom: GBP 1,200–2,500 per eye
• Thailand: USD 800–1,800 per eye at internationally accredited centres (Bangkok, Phuket)
• UAE / Dubai: AED 4,000–12,000 per eye (USD 1,090–3,270)
• Turkey: USD 600–1,400 per eye — a leading medical tourism destination for LASIK

Medical tourism for LASIK is common, with India, Thailand, and Turkey offering internationally accredited centres at 40–70% cost savings compared to the United States. Patients should verify surgeon credentials, laser platform recency (equipment <5 years old), and access to post-operative care in their home country before travelling.

Multiple refractive surgical alternatives exist for patients who are ineligible for LASIK or who prefer a different approach:

PRK (Photorefractive Keratectomy)

The surface ablation predecessor to LASIK. No flap is created — the epithelium is removed, the excimer laser ablates the exposed Bowman layer and anterior stroma, and the epithelium regenerates over 3–5 days. Advantages: no flap (no ectasia risk from RSB thinning, no dislocation risk), suitable for thinner corneas and contact sport athletes. Disadvantages: more painful recovery, slower visual rehabilitation (1–4 weeks to functional vision), higher haze risk (managed with mitomycin C 0.02% application). Long-term visual outcomes are equivalent to LASIK at 12 months.

SMILE (Small Incision Lenticule Extraction)

A flapless, all-femtosecond procedure where a precisely shaped lenticule of intrastromal tissue is created by the femtosecond laser and extracted through a 2–4 mm arc incision, changing corneal curvature. Only the VisuMax (Zeiss) and ATOS (Zeiss) platforms are FDA-approved for SMILE (approved for myopia and myopic astigmatism). Advantages: flapless (no dislocation risk), significantly less dry eye (smaller incision severs fewer corneal nerves), suitable for athletes and military personnel. Disadvantages: correction range limited to approximately -10 D myopia, not yet approved for hyperopia in most markets, enhancement is more complex (surface ablation over the SMILE interface).

Phakic Intraocular Lens (PIOL — ICL, EVO ICL)

A lens is implanted in front of the natural crystalline lens (in the posterior chamber between iris and crystalline lens — ICL / EVO Visian ICL by STAAR Surgical). Indicated for patients with myopia beyond the safe LASIK correction range (-3 D to -20 D), thin corneas, or significant dry eye. Reversible (the lens can be explanted). Disadvantages: intraocular procedure (higher risk than corneal surgery — infection, cataract, raised IOP), surgeon dependency, and requires a patent peripheral iridotomy to prevent angle-closure.

Refractive Lens Exchange (RLE / CLE)

Replacement of the natural crystalline lens with a calculated power IOL — essentially cataract surgery performed on a clear, non-cataractous lens. Appropriate for patients over 45–50 with significant presbyopia or extreme hyperopia. Permanently eliminates the need for reading glasses when a multifocal or extended depth-of-focus IOL is used. Disadvantage: eliminates accommodation permanently (significant in younger patients) and carries the risks of intraocular surgery including rare but serious infection (endophthalmitis, 0.02%).

Orthokeratology (Ortho-K)

Rigid gas-permeable contact lenses worn overnight that temporarily reshape the corneal epithelium to correct myopia. Reversible and non-surgical. Primarily used in children and adolescents for myopia control. Daily visual acuity depends on consistent overnight lens wear; not suitable as a permanent correction.